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ABSTRACT
Parvovirus B19 (B19V) is a single-stranded DNA virus of the family Parvoviridae and genus Erythrovirus. Parvovirus B19 infection 
can present with myriads of clinical diseases and syndromes; liver manifestations and hepatitis are examples of them. The majority 
of the available literature regarding acute parvovirus B19 induced fulminant hepatic failure has described cases involving children.
Acute fulminant liver failure caused by acute parvovirus B19 infection in a pregnant lady is rarely reported in the literature. Here, we 
report a case of fulminant liver failure in a 28-year-old pregnant lady presenting as a diagnostic dilemma, the etiology of which was 
eventually detected as acute Parvovirus B19 infection. Since Parvovirus B19 is a potential cause of non-A, non-E fulminant hepatic 
failure, an early diagnosis is of utmost importance as treatment options are limited.
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Acute liver failure is a rare clinical syndrome with an annual incidence of fewer than 10 cases per million population in the developed world [1]. Parvovirus B19 (B19V) is a 
single-stranded DNA virus of the family Parvoviridae and genus 
Erythrovirus. Parvovirus B19 infection can present with myriads 
of clinical diseases and syndromes; liver manifestations and 
hepatitis are examples of them. Parvovirus B19 is an erythrovirus 
that can only be replicated in pronormoblasts and hepatocytes, 
and other cells which have globosides and glycosphingolipids in 
their membrane can also be affected by direct virus injury [2]. 
The majority of the available literature regarding acute 
parvovirus B19 induced fulminant hepatic failure have described 
cases involving children [3,4]. Parvovirus B19 has been 
implicated as an important cause of non-A and non-E hepatitis 
[5,6]. Acute fulminant liver failure caused by acute Parvovirus 
B19 infection in a pregnant lady is rarely reported in the literature.
There is no specific treatment for parvovirus B19 related liver 
diseases, but triple therapy regimen may be effective consisting of 
immunoglobulin, dehydrohydrocortisone, and cyclosporine [2].
CASE REPORT
A 28-year-old pregnant lady presented to us with a 1-month 
history of anasarca, icterus, easy fatiguability, episodic epistaxis, 
and pruritus. She was a housewife with no personal or family 
history of known medical ailments or any history of travel. 
Clinical examination revealed an icteric, afebrile, conscious 
lady with normal hemodynamic parameters (blood pressure 
of 110/60 mmHg, pulse rate of 88/min and respiratory rate of 
22/min) and abdominal distension (free-fluid present) with no 
evidence of hepatomegaly/splenomegaly. She had pallor and 
significant bilateral pitting pedal edema. No skin rashes/bleeding 
manifestations were noticed. Her chest and cardiovascular 
examinations were normal and neurological examination revealed 
no focal deficits or tremors or flaps.
Complete blood counts showed anemia (Hg-8.6 g/dl), 
thrombocytopenia (platelets- 80,000 cells/mm3) with evidence 
of normocytic normochromic RBCs on peripheral smear. Iron 
studies showing decreased iron levels. Her liver function tests 
(LFT) showed direct hyperbilirubinemia (total bilirubin - 26, 
direct bilirubin – 15 mg/dl), modest elevation of enzymes 
(serum glutamic oxaloacetic transaminase – 114I U/L, serum 
Glutamic Pyruvic Transaminase – 112.49 IU/L) with marked 
elevation of serum alkaline phosphatase (331 IU/L). Prothrombin 
time (PT) was prolonged (22 sec) with deranged International 
Normalised Ratio (INR-2.1). Kidney function tests (Urea-15mg/
dl, Creatinine-0.66mg/dl) were normal. An abdominal ultrasound 
revealed 25 weeks single live fetus with the gross peritoneal 
collection and a coarse liver. A diagnostic ascitic tap revealed 
high serum ascitic albumin gradient (1.8), low protein (1.1 gm%) 
and lymphocyte - predominant fluid. Viral markers for Hepatitis 
A, E, B and C were all negative. IgM anti-Epstein Barr virus was 
negative and IgM anti-parvoB19 was negative. Parvo B19 DNA 
was detected in serum. Antinuclear antibody (ANA), anti-liver 
kidney microsomal-1, anti-soluble liver antigen, anti-smooth 
muscle antibody, and anti-mitochondrial antibody were all 
negative. Upper gastrointestinal endoscopy revealed evidence of 
portal gastropathy. Ceruloplasmin was modestly reduced (36.5) 
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with absent Kayser Fleischer ring on slit lamp exam. Serum bile 
acids were normal (0.8 mg/dl).
The patient was managed conservatively with iron and 
folate supplementation, ursodeoxycholic acid, syrup lactulose, 
potassium supplementation, Rifaximine and Torsemide. She 
had been transfused with 6 units of fresh frozen plasma and 
also received Injection Vitamin K.The patient had a gradual 
downhill clinical course with Model for End-Stage Liver Disease 
(MELD) score deteriorating from 23 to 27 (Fig. 1). Attendants 
were counseled for intravenous Immunoglobulin, plasmapheresis 
and liver transplantation. The patient had a massive upper 
gastrointestinal bleed (probably due to deranged INR) with 
alteration of sensorium (hepatic encephalopathy) and went into 
irreversible shock. Unfortunately, she could not be revived 
despite all supportive measures.
DISCUSSION
Parvovirus B19 infection is a common infection in childhood as 
well as in pregnancy. The clinical presentations can be benign 
to life-threatening as was in our case.As the majority of patients 
with liver failure are diagnosed as “indeterminate”, a sound 
knowledge of Parvovirus B19 associated liver disease is limited. 
The mechanism by which Parvovirus B19 infection may result 
in hepatic injury is not clear. Hepatic cell damage related to 
direct viral invasion is one possibility.Alternatively, an injury 
may result as an indirect consequence of the immune response 
directed against the virus [7]. 
Parvovirus B19 infection has been reported as a rare 
cause of fulminant liver failure in children requiring liver 
transplantation [8]. A case of non-A-E fatal acute liver failure 
in an immunocompetent child with B19 infection had also been 
described [9]. Our knowledge of Parvovirus B19 as a potential 
cause of non-A, non-E acute liver failure in a pregnant woman is 
limited. Although B19 IgM antibodies are rarely found in those 
patients that are not associated with an outbreak and without 
an illness suggesting parvovirus infection, there is always a 
possibility of false-positive results among these cases, even when 
using highly accurate tests [10]. Parvo B19 DNA by polymerase 
chain reaction (PCR) was positive in serum in our case. Detection 
of ParvovirusB19 DNA and VP1 antigen detection in a liver 
biopsy specimen would confirm the presence of active viral 
infection [10]. A liver biopsy was planned but could not be done 
in our case because of rapid clinical deterioration of the patient. 
Leptospirosis, Scrub Typhus and malarial hepatitis (Falciparum) 
were easily ruled out due to lack of fever and negative smear 
examination and serologies. A meticulous drug history revealed 
no specific hepatotoxic drug ingestion.Testing for rare causes of 
non-A, non-E Hepatitis like SEN Virus, Toga virus, and Herpes 
Simplex virus were not done.
Parvo B19 infection in pregnancy is quite common and can 
cause a wide range of clinical outcomes ranging from fetal hydrops 
and intrauterine fetal death to maternal arthritis, transient aplastic 
crisis, myocarditis or asymptomatic [11,12]. The association of 
Parvovirus B19 and fulminant hepatitis in adults is well-established 
in the literature [13,14] but is rarely reported in pregnancy. In our 
case, with all other possible etiologies of fulminant hepatitis being 
ruled out, acute Parvovirus B19 induced liver failure seems to 
be the most logical diagnosis.Liver transplantation would have 
been the ideal treatment modality in such cases of fulminant liver 
failure as was reported in a 2009 study [15].
CONCLUSION
Since Parvovirus B19 is a potential cause of non-A, non-E 
fulminant hepatic failure, early diagnosis is of utmost importance 
as treatment options are limited. The physician should keep 
Parvovirus B19 in differentials while ordering tests for acute 
hepatitis as timely diagnosis and management could alter the 
patient’s clinical course.  
Figure 1: Line diagram showing progressive derangement of liver function
T: Total; D: Direct; MELD: Model for End Stage Liver Disease Score
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